Cannabis Investment Report |
December 2017
Representative Dosage Amounts
Desired Effect or Ailment Dosage “High” 10 mg THC Anxiety, depression, spasms 25 mg CBD Cancer 25 mg CBD Chronic pain 2.5-20 mg THC Epileptic seizures 200-300 mg CBD Glaucoma 20-40 mg CBD Increased appetite 2.5 mg THC
Multiple sclerosis 2.5-120 mg THC 40-1,280 mg CBD
40-160 mg CBD
Schizophrenia Sleep disorders
Neither the potential medicinal benefits and therapeutic
Dosage Ratio (THC:CBD)
10:1 to 100:1 1:10 1:1 10:1 1:5 1:2 to 1:4 5:1 1:1 1:4 to 1:128 1:4 to 1:16
applications of cannabis consumption nor
the negative side effects of cannabis use have been thoroughly researched by medical science. Short-
term negative side effects are believed by some to include sensory distortion, panic, anxiety, poor coor-
dination of movement, reduced reaction time, lethargy or drowsiness, depression and elevated heart
rate. Longer-term effects may include suppression of the immune system, growth disorders, destruc-
tion of lung fibers, brain lesions, reduced sexual capacity, difficulties with concentration, reduced abil-
ity to learn and retain information, and personality and moo about whether cannabis consumption may lead to the abuse “gateway drug” debate).
30
d changes. There is also an ongoing debate of more harmful substances (the so-called
© 2017 Ackrell Capital, LLC | Member FINRA/SIPC
HOUSE_OVERSIGHT_024666